T2 Biosystems, Inc. (NASDAQ:TTOO) management will conduct a conference call for 11th August 2020 at 4:30 PM Eastern Time to discuss financial results and companys performance for 2Q20.
The conference call will also be available live on the website www.t2biosystems.com
Earnings Expectation
T2 Biosystems, Inc. diagnostic products and services provider, is reporting second quarter earnings results on Tuesday 11th August 2020, after market close. The consensus estimates from Thomson Reuters are loss of $ 0.15 per share. For the full year, analysts predict revenues of $ 14.55 million, while looking forward to loss of $ 0.62 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 14.00 million ~ $ 17.00 million
Click Here For More Historical Outlooks Of T2 Biosystems, Inc.
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. It provides T2 Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company also offers T2Dx, a bench-top instrument for detecting pathogens associated with sepsis and Lyme disease, and other applications, as well as T2Candida panel that identifies the species of Candida, a fungal pathogen known to cause sepsis directly from whole blood.
